QuidelOrtho Corp

QDEL

14.780USD

-0.820-5.26%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

QuidelOrtho Corp's Score

Industry at a Glance

Industry Ranking

72 / 208

Overall Ranking

187 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

QuidelOrtho Corp Highlights

StrengthsRisks

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Overvalued

The company’s latest PE is -0.85, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 84.07M shares, decreasing 19.39% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 7.54M shares of this stock.

Analyst Rating

Based on 8 analysts

Hold

Current Rating

35.167

Target Price

+125.43%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of QuidelOrtho Corp is 5.71, ranking 188 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 699.90M, representing a year-over-year decrease of 3.74%, while its net profit experienced a year-over-year decrease of 3583.42%.

Score

Industry at a Glance

Previous score

5.71

Change

0



Financials

3.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.05

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.24

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.43

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.14

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of QuidelOrtho Corp is 8.38, ranking 23 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.85, which is -1214.63% below the recent high of 9.47 and -58087.66% above the recent low of -494.25.

Score

Industry at a Glance

Previous score

8.38

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 72/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of QuidelOrtho Corp is 6.75, ranking 163 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 32.00, with a high of 60.00 and a low of 22.00.

Score

Industry at a Glance

Previous score

6.75

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of QuidelOrtho Corp is 6.52, ranking 114 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 20.16 and the support level at 11.92, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.56

Change

-0.04

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of QuidelOrtho Corp is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 123.75%, representing a quarter-over-quarter increase of 5.82%. The largest institutional shareholder is The Vanguard, holding a total of 7.54M shares, representing 11.07% of shares outstanding, with 11.38% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Investment Management, Inc.

11.01M

-1.11%

BlackRock Institutional Trust Company, N.A.

9.32M

+0.42%

The Vanguard Group, Inc.

Star Investors

7.60M

-2.13%

Fidelity Management & Research Company LLC

4.44M

+73.81%

Rubric Capital Management LP

4.64M

--

Invesco Advisers, Inc.

2.66M

+100.02%

Newtyn Management, LLC

2.70M

+58.30%

Dimensional Fund Advisors, L.P.

2.86M

+13.98%

State Street Investment Management (US)

2.67M

-1.19%

American Century Investment Management, Inc.

2.12M

+10.44%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of QuidelOrtho Corp is 4.84, ranking 95 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.92. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. QuidelOrtho Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

QuidelOrtho Corp

QDEL

6.82 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment